The global market for Alpha Synuclein was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Alpha Synuclein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Alpha Synuclein is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Alpha Synuclein include AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Alpha Synuclein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Synuclein.

The Alpha Synuclein market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alpha Synuclein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alpha Synuclein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Alpha Synuclein Market Report

Report Metric	Details
Report Name	Alpha Synuclein Market
Segment by Type	AV-1950R AV-1947D BAN-0805 BIIB-054 DPC-003 Others
Segment by Application	Multiple System Atrophy Neurodegenerateive Disease Lewy Body Dementia Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, nLife Therapeutics SL, Prothena Corp Plc, QR Pharma Inc, reMYND NV
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alpha Synuclein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alpha Synuclein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Alpha Synuclein Market report?

Ans: The main players in the Alpha Synuclein Market are AC Immune SA, AFFiRiS AG, BioArctic AB, Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, nLife Therapeutics SL, Prothena Corp Plc, QR Pharma Inc, reMYND NV

What are the Application segmentation covered in the Alpha Synuclein Market report?

Ans: The Applications covered in the Alpha Synuclein Market report are Multiple System Atrophy, Neurodegenerateive Disease, Lewy Body Dementia, Others

What are the Type segmentation covered in the Alpha Synuclein Market report?

Ans: The Types covered in the Alpha Synuclein Market report are AV-1950R, AV-1947D, BAN-0805, BIIB-054, DPC-003, Others

1 Alpha Synuclein Market Overview

1.1 Product Definition

1.2 Alpha Synuclein by Type

1.2.1 Global Alpha Synuclein Market Value Comparison by Type (2024 VS 2031)

1.2.2 AV-1950R

1.2.3 AV-1947D

1.2.4 BAN-0805

1.2.5 BIIB-054

1.2.6 DPC-003

1.2.7 Others

1.3 Alpha Synuclein by Application

1.3.1 Global Alpha Synuclein Market Value by Application (2024 VS 2031)

1.3.2 Multiple System Atrophy

1.3.3 Neurodegenerateive Disease

1.3.4 Lewy Body Dementia

1.3.5 Others

1.4 Global Alpha Synuclein Market Size Estimates and Forecasts

1.4.1 Global Alpha Synuclein Revenue 2020-2031

1.4.2 Global Alpha Synuclein Sales 2020-2031

1.4.3 Global Alpha Synuclein Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Alpha Synuclein Market Competition by Manufacturers

2.1 Global Alpha Synuclein Sales Market Share by Manufacturers (2020-2025)

2.2 Global Alpha Synuclein Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Alpha Synuclein Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Alpha Synuclein, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Alpha Synuclein, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Alpha Synuclein, Product Type & Application

2.7 Global Key Manufacturers of Alpha Synuclein, Date of Enter into This Industry

2.8 Global Alpha Synuclein Market Competitive Situation and Trends

2.8.1 Global Alpha Synuclein Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Alpha Synuclein Players Market Share by Revenue

2.8.3 Global Alpha Synuclein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Alpha Synuclein Market Scenario by Region

3.1 Global Alpha Synuclein Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Alpha Synuclein Sales by Region: 2020-2031

3.2.1 Global Alpha Synuclein Sales by Region: 2020-2025

3.2.2 Global Alpha Synuclein Sales by Region: 2026-2031

3.3 Global Alpha Synuclein Revenue by Region: 2020-2031

3.3.1 Global Alpha Synuclein Revenue by Region: 2020-2025

3.3.2 Global Alpha Synuclein Revenue by Region: 2026-2031

3.4 North America Alpha Synuclein Market Facts & Figures by Country

3.4.1 North America Alpha Synuclein Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Alpha Synuclein Sales by Country (2020-2031)

3.4.3 North America Alpha Synuclein Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Alpha Synuclein Market Facts & Figures by Country

3.5.1 Europe Alpha Synuclein Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Alpha Synuclein Sales by Country (2020-2031)

3.5.3 Europe Alpha Synuclein Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Alpha Synuclein Market Facts & Figures by Region

3.6.1 Asia Pacific Alpha Synuclein Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Alpha Synuclein Sales by Region (2020-2031)

3.6.3 Asia Pacific Alpha Synuclein Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Alpha Synuclein Market Facts & Figures by Country

3.7.1 Latin America Alpha Synuclein Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Alpha Synuclein Sales by Country (2020-2031)

3.7.3 Latin America Alpha Synuclein Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Alpha Synuclein Market Facts & Figures by Country

3.8.1 Middle East and Africa Alpha Synuclein Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Alpha Synuclein Sales by Country (2020-2031)

3.8.3 Middle East and Africa Alpha Synuclein Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Alpha Synuclein Sales by Type (2020-2031)

4.1.1 Global Alpha Synuclein Sales by Type (2020-2025)

4.1.2 Global Alpha Synuclein Sales by Type (2026-2031)

4.1.3 Global Alpha Synuclein Sales Market Share by Type (2020-2031)

4.2 Global Alpha Synuclein Revenue by Type (2020-2031)

4.2.1 Global Alpha Synuclein Revenue by Type (2020-2025)

4.2.2 Global Alpha Synuclein Revenue by Type (2026-2031)

4.2.3 Global Alpha Synuclein Revenue Market Share by Type (2020-2031)

4.3 Global Alpha Synuclein Price by Type (2020-2031)

5 Segment by Application

5.1 Global Alpha Synuclein Sales by Application (2020-2031)

5.1.1 Global Alpha Synuclein Sales by Application (2020-2025)

5.1.2 Global Alpha Synuclein Sales by Application (2026-2031)

5.1.3 Global Alpha Synuclein Sales Market Share by Application (2020-2031)

5.2 Global Alpha Synuclein Revenue by Application (2020-2031)

5.2.1 Global Alpha Synuclein Revenue by Application (2020-2025)

5.2.2 Global Alpha Synuclein Revenue by Application (2026-2031)

5.2.3 Global Alpha Synuclein Revenue Market Share by Application (2020-2031)

5.3 Global Alpha Synuclein Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AC Immune SA

6.1.1 AC Immune SA Company Information

6.1.2 AC Immune SA Description and Business Overview

6.1.3 AC Immune SA Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AC Immune SA Alpha Synuclein Product Portfolio

6.1.5 AC Immune SA Recent Developments/Updates

6.2 AFFiRiS AG

6.2.1 AFFiRiS AG Company Information

6.2.2 AFFiRiS AG Description and Business Overview

6.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AFFiRiS AG Alpha Synuclein Product Portfolio

6.2.5 AFFiRiS AG Recent Developments/Updates

6.3 BioArctic AB

6.3.1 BioArctic AB Company Information

6.3.2 BioArctic AB Description and Business Overview

6.3.3 BioArctic AB Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.3.4 BioArctic AB Alpha Synuclein Product Portfolio

6.3.5 BioArctic AB Recent Developments/Updates

6.4 Biogen Inc

6.4.1 Biogen Inc Company Information

6.4.2 Biogen Inc Description and Business Overview

6.4.3 Biogen Inc Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Biogen Inc Alpha Synuclein Product Portfolio

6.4.5 Biogen Inc Recent Developments/Updates

6.5 Evotec AG

6.5.1 Evotec AG Company Information

6.5.2 Evotec AG Description and Business Overview

6.5.3 Evotec AG Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Evotec AG Alpha Synuclein Product Portfolio

6.5.5 Evotec AG Recent Developments/Updates

6.6 Genmab A/S

6.6.1 Genmab A/S Company Information

6.6.2 Genmab A/S Description and Business Overview

6.6.3 Genmab A/S Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Genmab A/S Alpha Synuclein Product Portfolio

6.6.5 Genmab A/S Recent Developments/Updates

6.7 H. Lundbeck A/S

6.7.1 H. Lundbeck A/S Company Information

6.7.2 H. Lundbeck A/S Description and Business Overview

6.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.7.4 H. Lundbeck A/S Alpha Synuclein Product Portfolio

6.7.5 H. Lundbeck A/S Recent Developments/Updates

6.8 ICB International Inc

6.8.1 ICB International Inc Company Information

6.8.2 ICB International Inc Description and Business Overview

6.8.3 ICB International Inc Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.8.4 ICB International Inc Alpha Synuclein Product Portfolio

6.8.5 ICB International Inc Recent Developments/Updates

6.9 MedImmune LLC

6.9.1 MedImmune LLC Company Information

6.9.2 MedImmune LLC Description and Business Overview

6.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.9.4 MedImmune LLC Alpha Synuclein Product Portfolio

6.9.5 MedImmune LLC Recent Developments/Updates

6.10 Neuropore Therapies Inc

6.10.1 Neuropore Therapies Inc Company Information

6.10.2 Neuropore Therapies Inc Description and Business Overview

6.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Neuropore Therapies Inc Alpha Synuclein Product Portfolio

6.10.5 Neuropore Therapies Inc Recent Developments/Updates

6.11 nLife Therapeutics SL

6.11.1 nLife Therapeutics SL Company Information

6.11.2 nLife Therapeutics SL Description and Business Overview

6.11.3 nLife Therapeutics SL Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.11.4 nLife Therapeutics SL Alpha Synuclein Product Portfolio

6.11.5 nLife Therapeutics SL Recent Developments/Updates

6.12 Prothena Corp Plc

6.12.1 Prothena Corp Plc Company Information

6.12.2 Prothena Corp Plc Description and Business Overview

6.12.3 Prothena Corp Plc Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Prothena Corp Plc Alpha Synuclein Product Portfolio

6.12.5 Prothena Corp Plc Recent Developments/Updates

6.13 QR Pharma Inc

6.13.1 QR Pharma Inc Company Information

6.13.2 QR Pharma Inc Description and Business Overview

6.13.3 QR Pharma Inc Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.13.4 QR Pharma Inc Alpha Synuclein Product Portfolio

6.13.5 QR Pharma Inc Recent Developments/Updates

6.14 reMYND NV

6.14.1 reMYND NV Company Information

6.14.2 reMYND NV Description and Business Overview

6.14.3 reMYND NV Alpha Synuclein Sales, Revenue and Gross Margin (2020-2025)

6.14.4 reMYND NV Alpha Synuclein Product Portfolio

6.14.5 reMYND NV Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Alpha Synuclein Industry Chain Analysis

7.2 Alpha Synuclein Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Alpha Synuclein Production Mode & Process Analysis

7.4 Alpha Synuclein Sales and Marketing

7.4.1 Alpha Synuclein Sales Channels

7.4.2 Alpha Synuclein Distributors

7.5 Alpha Synuclein Customer Analysis

8 Alpha Synuclein Market Dynamics

8.1 Alpha Synuclein Industry Trends

8.2 Alpha Synuclein Market Drivers

8.3 Alpha Synuclein Market Challenges

8.4 Alpha Synuclein Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

ICB International Inc

MedImmune

Neuropore Therapies Inc

nLife Therapeutics SL

Prothena Corp Plc

QR Pharma Inc

reMYND NV

List of Tables

Table 1. Global Alpha Synuclein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Alpha Synuclein Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Alpha Synuclein Market Competitive Situation by Manufacturers in 2024

Table 4. Global Alpha Synuclein Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Alpha Synuclein Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Alpha Synuclein Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Alpha Synuclein Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Alpha Synuclein Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Alpha Synuclein, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Alpha Synuclein, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Alpha Synuclein, Product Type & Application

Table 12. Global Key Manufacturers of Alpha Synuclein, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Alpha Synuclein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Synuclein as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Alpha Synuclein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Alpha Synuclein Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Alpha Synuclein Sales Market Share by Region (2020-2025)

Table 19. Global Alpha Synuclein Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Alpha Synuclein Sales Market Share by Region (2026-2031)

Table 21. Global Alpha Synuclein Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Alpha Synuclein Revenue Market Share by Region (2020-2025)

Table 23. Global Alpha Synuclein Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Alpha Synuclein Revenue Market Share by Region (2026-2031)

Table 25. North America Alpha Synuclein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Alpha Synuclein Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Alpha Synuclein Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Alpha Synuclein Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Alpha Synuclein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Alpha Synuclein Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Alpha Synuclein Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Alpha Synuclein Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Alpha Synuclein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Alpha Synuclein Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Alpha Synuclein Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Alpha Synuclein Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Alpha Synuclein Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Alpha Synuclein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Alpha Synuclein Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Alpha Synuclein Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Alpha Synuclein Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Alpha Synuclein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Alpha Synuclein Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Alpha Synuclein Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Alpha Synuclein Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Alpha Synuclein Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Alpha Synuclein Sales (K Pcs) by Type (2020-2025)

Table 51. Global Alpha Synuclein Sales (K Pcs) by Type (2026-2031)

Table 52. Global Alpha Synuclein Sales Market Share by Type (2020-2025)

Table 53. Global Alpha Synuclein Sales Market Share by Type (2026-2031)

Table 54. Global Alpha Synuclein Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Alpha Synuclein Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Alpha Synuclein Revenue Market Share by Type (2020-2025)

Table 57. Global Alpha Synuclein Revenue Market Share by Type (2026-2031)

Table 58. Global Alpha Synuclein Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Alpha Synuclein Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Alpha Synuclein Sales (K Pcs) by Application (2020-2025)

Table 61. Global Alpha Synuclein Sales (K Pcs) by Application (2026-2031)

Table 62. Global Alpha Synuclein Sales Market Share by Application (2020-2025)

Table 63. Global Alpha Synuclein Sales Market Share by Application (2026-2031)

Table 64. Global Alpha Synuclein Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Alpha Synuclein Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Alpha Synuclein Revenue Market Share by Application (2020-2025)

Table 67. Global Alpha Synuclein Revenue Market Share by Application (2026-2031)

Table 68. Global Alpha Synuclein Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Alpha Synuclein Price (USD/Pcs) by Application (2026-2031)

Table 70. AC Immune SA Company Information

Table 71. AC Immune SA Description and Business Overview

Table 72. AC Immune SA Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. AC Immune SA Alpha Synuclein Product

Table 74. AC Immune SA Recent Developments/Updates

Table 75. AFFiRiS AG Company Information

Table 76. AFFiRiS AG Description and Business Overview

Table 77. AFFiRiS AG Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. AFFiRiS AG Alpha Synuclein Product

Table 79. AFFiRiS AG Recent Developments/Updates

Table 80. BioArctic AB Company Information

Table 81. BioArctic AB Description and Business Overview

Table 82. BioArctic AB Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. BioArctic AB Alpha Synuclein Product

Table 84. BioArctic AB Recent Developments/Updates

Table 85. Biogen Inc Company Information

Table 86. Biogen Inc Description and Business Overview

Table 87. Biogen Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Biogen Inc Alpha Synuclein Product

Table 89. Biogen Inc Recent Developments/Updates

Table 90. Evotec AG Company Information

Table 91. Evotec AG Description and Business Overview

Table 92. Evotec AG Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Evotec AG Alpha Synuclein Product

Table 94. Evotec AG Recent Developments/Updates

Table 95. Genmab A/S Company Information

Table 96. Genmab A/S Description and Business Overview

Table 97. Genmab A/S Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Genmab A/S Alpha Synuclein Product

Table 99. Genmab A/S Recent Developments/Updates

Table 100. H. Lundbeck A/S Company Information

Table 101. H. Lundbeck A/S Description and Business Overview

Table 102. H. Lundbeck A/S Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. H. Lundbeck A/S Alpha Synuclein Product

Table 104. H. Lundbeck A/S Recent Developments/Updates

Table 105. ICB International Inc Company Information

Table 106. ICB International Inc Description and Business Overview

Table 107. ICB International Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. ICB International Inc Alpha Synuclein Product

Table 109. ICB International Inc Recent Developments/Updates

Table 110. MedImmune LLC Company Information

Table 111. MedImmune LLC Description and Business Overview

Table 112. MedImmune LLC Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. MedImmune LLC Alpha Synuclein Product

Table 114. MedImmune LLC Recent Developments/Updates

Table 115. Neuropore Therapies Inc Company Information

Table 116. Neuropore Therapies Inc Description and Business Overview

Table 117. Neuropore Therapies Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. Neuropore Therapies Inc Alpha Synuclein Product

Table 119. Neuropore Therapies Inc Recent Developments/Updates

Table 120. nLife Therapeutics SL Company Information

Table 121. nLife Therapeutics SL Description and Business Overview

Table 122. nLife Therapeutics SL Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 123. nLife Therapeutics SL Alpha Synuclein Product

Table 124. nLife Therapeutics SL Recent Developments/Updates

Table 125. Prothena Corp Plc Company Information

Table 126. Prothena Corp Plc Description and Business Overview

Table 127. Prothena Corp Plc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 128. Prothena Corp Plc Alpha Synuclein Product

Table 129. Prothena Corp Plc Recent Developments/Updates

Table 130. QR Pharma Inc Company Information

Table 131. QR Pharma Inc Description and Business Overview

Table 132. QR Pharma Inc Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 133. QR Pharma Inc Alpha Synuclein Product

Table 134. QR Pharma Inc Recent Developments/Updates

Table 135. reMYND NV Company Information

Table 136. reMYND NV Description and Business Overview

Table 137. reMYND NV Alpha Synuclein Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 138. reMYND NV Alpha Synuclein Product

Table 139. reMYND NV Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Alpha Synuclein Distributors List

Table 143. Alpha Synuclein Customers List

Table 144. Alpha Synuclein Market Trends

Table 145. Alpha Synuclein Market Drivers

Table 146. Alpha Synuclein Market Challenges

Table 147. Alpha Synuclein Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Alpha Synuclein

Figure 2. Global Alpha Synuclein Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Alpha Synuclein Market Share by Type: 2024 & 2031

Figure 4. AV-1950R Product Picture

Figure 5. AV-1947D Product Picture

Figure 6. BAN-0805 Product Picture

Figure 7. BIIB-054 Product Picture

Figure 8. DPC-003 Product Picture

Figure 9. Others Product Picture

Figure 10. Global Alpha Synuclein Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Alpha Synuclein Market Share by Application: 2024 & 2031

Figure 12. Multiple System Atrophy

Figure 13. Neurodegenerateive Disease

Figure 14. Lewy Body Dementia

Figure 15. Others

Figure 16. Global Alpha Synuclein Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Alpha Synuclein Market Size (2020-2031) & (US$ Million)

Figure 18. Global Alpha Synuclein Sales (2020-2031) & (K Pcs)

Figure 19. Global Alpha Synuclein Average Price (USD/Pcs) & (2020-2031)

Figure 20. Alpha Synuclein Report Years Considered

Figure 21. Alpha Synuclein Sales Share by Manufacturers in 2024

Figure 22. Global Alpha Synuclein Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Alpha Synuclein Players: Market Share by Revenue in Alpha Synuclein in 2024

Figure 24. Alpha Synuclein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Alpha Synuclein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Alpha Synuclein Sales Market Share by Country (2020-2031)

Figure 27. North America Alpha Synuclein Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Alpha Synuclein Sales Market Share by Country (2020-2031)

Figure 31. Europe Alpha Synuclein Revenue Market Share by Country (2020-2031)

Figure 32. Germany Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Alpha Synuclein Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Alpha Synuclein Revenue Market Share by Region (2020-2031)

Figure 39. China Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Alpha Synuclein Sales Market Share by Country (2020-2031)

Figure 50. Latin America Alpha Synuclein Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Alpha Synuclein Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Alpha Synuclein Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. UAE Alpha Synuclein Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Alpha Synuclein by Type (2020-2031)

Figure 60. Global Revenue Market Share of Alpha Synuclein by Type (2020-2031)

Figure 61. Global Alpha Synuclein Price (USD/Pcs) by Type (2020-2031)

Figure 62. Global Sales Market Share of Alpha Synuclein by Application (2020-2031)

Figure 63. Global Revenue Market Share of Alpha Synuclein by Application (2020-2031)

Figure 64. Global Alpha Synuclein Price (USD/Pcs) by Application (2020-2031)

Figure 65. Alpha Synuclein Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4R20263

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Online Speech Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39V19943

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Nerve Repair and Regeneration Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10C17235

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Neurological Disease Model Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-7M17348

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Alpha Synuclein Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28J7041

Global Alpha Synuclein Market Research Report 2025

FEATURED COMPANIES

Alpha Synuclein Market

Report Scope

Scope of Alpha Synuclein Market Report

Core Chapters

FAQ for this report

Who are the main players in the Alpha Synuclein Market report?

What are the Application segmentation covered in the Alpha Synuclein Market report?

What are the Type segmentation covered in the Alpha Synuclein Market report?

FEATURED COMPANIES

RELATED REPORTS